Global Transdermal Patch Supply, Demand and Key Producers, 2026-2032

January 2026 | 150 pages | ID: G6CA09488D5CEN
GlobalInfoResearch

US$ 4,480.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The global Transdermal Patch market size is expected to reach $ 9833 million by 2032, rising at a market growth of 3.5% CAGR during the forecast period (2026-2032).

Transdermal Patch is a medicated adhesive patch that is placed on the skin to deliver a specific dose of medication through the skin and into the bloodstream.Transdermal Patches include fentanyl transdermal patch, nicotine transdermal patch, buprenorphine transdermal patch, clonidine transdermal patch, oxybutynin transdermal patch, estradiol transdermal patch, nitroglycerin transdermal patch and many others.

Transdermal Patches are mainly classified into the following types: Methyl Salicylate-based Patches, Rivastigmine Patches, Fentanyl Patches, Lidocaine Patches, Diclofenac Patches, Nicotine Patches and others. Methyl Salicylate-based segment accounted for the larger part of the revenue market, with 18%, followed by Lidocaine Patches, with 15%.

Transdermal Patches can delivery drugs through Rx Channel or OTC Channel. The former took a larger market share, with its sales volume accounting for about 76% of the total.

Hisamitsu Pharmaceutical, Johnson & Johnson, Nitto Denko and Mylan are the Top 4 players of the global Transdermal Patch market. They took up about 42% of the global market in 2019.

This report studies the global Transdermal Patch production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Transdermal Patch and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Transdermal Patch that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Transdermal Patch total production and demand, 2021-2032, (M Pcs)

Global Transdermal Patch total production value, 2021-2032, (USD Million)
Global Transdermal Patch production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (M Pcs), (based on production site)
Global Transdermal Patch consumption by region & country, CAGR, 2021-2032 & (M Pcs)
U.S. VS China: Transdermal Patch domestic production, consumption, key domestic manufacturers and share
Global Transdermal Patch production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (M Pcs)

Global Transdermal Patch production by Type, production, value, CAGR, 2021-2032, (USD Million) & (M Pcs)

Global Transdermal Patch production by Application, production, value, CAGR, 2021-2032, (USD Million) & (M Pcs)

This report profiles key players in the global Transdermal Patch market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Hisamitsu Pharmaceutical, Johnson & Johnson, Novartis, UCB Pharma, Mylan, Teva Pharmaceutical, Nitto Denko, Gr?nenthal, IBSA Group, GSK, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Transdermal Patch market

Detailed Segmentation:

Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (M Pcs) and average price (USD/Pc) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.

Global Transdermal Patch Market, By Region:
  • United States
  • China
  • Europe
  • Japan
  • South Korea
  • ASEAN
  • India
  • Rest of World
Global Transdermal Patch Market, Segmentation by Type:
  • Methyl Salicylate-based Patch
  • Rivastigmine Transdermal Patch
  • Fentanyl Transdermal Patch
  • Lidocaine Patch
  • Diclofenac Patch
  • Nicotine Transdermal Patch
  • Others
Global Transdermal Patch Market, Segmentation by Application:
  • Rx Channel
  • OTC Channel
Companies Profiled:
  • Hisamitsu Pharmaceutical
  • Johnson & Johnson
  • Novartis
  • UCB Pharma
  • Mylan
  • Teva Pharmaceutical
  • Nitto Denko
  • Gr?nenthal
  • IBSA Group
  • GSK
  • Luye Pharma Group
  • Pfizer
  • Chattem
  • Dr Reddy’s Laboratories
  • Bayer
  • Mundipharma
  • Endo International
  • Beijing Tide Pharmaceutical
Key Questions Answered:
1. How big is the global Transdermal Patch market?
2. What is the demand of the global Transdermal Patch market?
3. What is the year over year growth of the global Transdermal Patch market?
4. What is the production and production value of the global Transdermal Patch market?
5. Who are the key producers in the global Transdermal Patch market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY

1.1 SCADA Introduction
1.2 World SCADA Market Size & Forecast (2021 & 2025 & 2032)
1.3 World SCADA Total Market by Region (by Headquarter Location)
  1.3.1 World SCADA Market Size by Region (2021-2032), (by Headquarter Location)
  1.3.2 United States Based Company SCADA Revenue (2021-2032)
  1.3.3 China Based Company SCADA Revenue (2021-2032)
  1.3.4 Europe Based Company SCADA Revenue (2021-2032)
  1.3.5 Japan Based Company SCADA Revenue (2021-2032)
  1.3.6 South Korea Based Company SCADA Revenue (2021-2032)
  1.3.7 ASEAN Based Company SCADA Revenue (2021-2032)
  1.3.8 India Based Company SCADA Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
  1.4.1 SCADA Market Drivers
  1.4.2 Factors Affecting Demand
  1.4.3 Major Market Trends

2 DEMAND SUMMARY

2.1 World SCADA Consumption Value (2021-2032)
2.2 World SCADA Consumption Value by Region
  2.2.1 World SCADA Consumption Value by Region (2021-2026)
  2.2.2 World SCADA Consumption Value Forecast by Region (2027-2032)
2.3 United States SCADA Consumption Value (2021-2032)
2.4 China SCADA Consumption Value (2021-2032)
2.5 Europe SCADA Consumption Value (2021-2032)
2.6 Japan SCADA Consumption Value (2021-2032)
2.7 South Korea SCADA Consumption Value (2021-2032)
2.8 ASEAN SCADA Consumption Value (2021-2032)
2.9 India SCADA Consumption Value (2021-2032)

3 WORLD SCADA COMPANIES COMPETITIVE ANALYSIS

3.1 World SCADA Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
  3.2.1 Global SCADA Industry Rank of Major Players
  3.2.2 Global Concentration Ratios (CR4) for SCADA in 2025
  3.2.3 Global Concentration Ratios (CR8) for SCADA in 2025
3.3 SCADA Company Evaluation Quadrant
3.4 SCADA Market: Overall Company Footprint Analysis
  3.4.1 SCADA Market: Region Footprint
  3.4.2 SCADA Market: Company Product Type Footprint
  3.4.3 SCADA Market: Company Product Application Footprint
3.5 Competitive Environment
  3.5.1 Historical Structure of the Industry
  3.5.2 Barriers of Market Entry
  3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity

4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)

4.1 United States VS China: SCADA Revenue Comparison (by Headquarter Location)
  4.1.1 United States VS China: SCADA Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
  4.1.2 United States VS China: SCADA Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: SCADA Consumption Value Comparison
  4.2.1 United States VS China: SCADA Consumption Value Comparison (2021 & 2025 & 2032)
  4.2.2 United States VS China: SCADA Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based SCADA Companies and Market Share, 2021-2026
  4.3.1 United States Based SCADA Companies, Headquarters (States, Country)
  4.3.2 United States Based Companies SCADA Revenue, (2021-2026)
4.4 China Based Companies SCADA Revenue and Market Share, 2021-2026
  4.4.1 China Based SCADA Companies, Company Headquarters (Province, Country)
  4.4.2 China Based Companies SCADA Revenue, (2021-2026)
4.5 Rest of World Based SCADA Companies and Market Share, 2021-2026
  4.5.1 Rest of World Based SCADA Companies, Headquarters (Province, Country)
  4.5.2 Rest of World Based Companies SCADA Revenue (2021-2026)

5 MARKET ANALYSIS BY TYPE

5.1 World SCADA Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
  5.2.1 Hardware
  5.2.2 Software
  5.2.3 Services
5.3 Market Segment by Type
  5.3.1 World SCADA Market Size by Type (2021-2026)
  5.3.2 World SCADA Market Size by Type (2027-2032)
  5.3.3 World SCADA Market Size Market Share by Type (2027-2032)

6 MARKET ANALYSIS BY APPLICATION

6.1 World SCADA Market Size Overview by Application: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Application
  6.2.1 Power & Energy
  6.2.2 Oil & Gas Industry
  6.2.3 Water & Waste Control
  6.2.4 Telecommunications
  6.2.5 Transportation
  6.2.6 Manufacturing Industry
  6.2.7 Others
6.3 Market Segment by Application
  6.3.1 World SCADA Market Size by Application (2021-2026)
  6.3.2 World SCADA Market Size by Application (2027-2032)
  6.3.3 World SCADA Market Size Market Share by Application (2021-2032)

7 COMPANY PROFILES

7.1 Schneider Electric SE (France)
  7.1.1 Schneider Electric SE (France) Details
  7.1.2 Schneider Electric SE (France) Major Business
  7.1.3 Schneider Electric SE (France) SCADA Product and Services
  7.1.4 Schneider Electric SE (France) SCADA Revenue, Gross Margin and Market Share (2021-2026)
  7.1.5 Schneider Electric SE (France) Recent Developments/Updates
  7.1.6 Schneider Electric SE (France) Competitive Strengths & Weaknesses
7.2 ABB (Switzerland)
  7.2.1 ABB (Switzerland) Details
  7.2.2 ABB (Switzerland) Major Business
  7.2.3 ABB (Switzerland) SCADA Product and Services
  7.2.4 ABB (Switzerland) SCADA Revenue, Gross Margin and Market Share (2021-2026)
  7.2.5 ABB (Switzerland) Recent Developments/Updates
  7.2.6 ABB (Switzerland) Competitive Strengths & Weaknesses
7.3 Siemens AG (Germany)
  7.3.1 Siemens AG (Germany) Details
  7.3.2 Siemens AG (Germany) Major Business
  7.3.3 Siemens AG (Germany) SCADA Product and Services
  7.3.4 Siemens AG (Germany) SCADA Revenue, Gross Margin and Market Share (2021-2026)
  7.3.5 Siemens AG (Germany) Recent Developments/Updates
  7.3.6 Siemens AG (Germany) Competitive Strengths & Weaknesses
7.4 Emerson (US)
  7.4.1 Emerson (US) Details
  7.4.2 Emerson (US) Major Business
  7.4.3 Emerson (US) SCADA Product and Services
  7.4.4 Emerson (US) SCADA Revenue, Gross Margin and Market Share (2021-2026)
  7.4.5 Emerson (US) Recent Developments/Updates
  7.4.6 Emerson (US) Competitive Strengths & Weaknesses
7.5 Rockwell Automation Inc. (US)
  7.5.1 Rockwell Automation Inc. (US) Details
  7.5.2 Rockwell Automation Inc. (US) Major Business
  7.5.3 Rockwell Automation Inc. (US) SCADA Product and Services
  7.5.4 Rockwell Automation Inc. (US) SCADA Revenue, Gross Margin and Market Share (2021-2026)
  7.5.5 Rockwell Automation Inc. (US) Recent Developments/Updates
  7.5.6 Rockwell Automation Inc. (US) Competitive Strengths & Weaknesses
7.6 Honeywell International Inc. (US)
  7.6.1 Honeywell International Inc. (US) Details
  7.6.2 Honeywell International Inc. (US) Major Business
  7.6.3 Honeywell International Inc. (US) SCADA Product and Services
  7.6.4 Honeywell International Inc. (US) SCADA Revenue, Gross Margin and Market Share (2021-2026)
  7.6.5 Honeywell International Inc. (US) Recent Developments/Updates
  7.6.6 Honeywell International Inc. (US) Competitive Strengths & Weaknesses
7.7 Mitsubishi Electric (Japan)
  7.7.1 Mitsubishi Electric (Japan) Details
  7.7.2 Mitsubishi Electric (Japan) Major Business
  7.7.3 Mitsubishi Electric (Japan) SCADA Product and Services
  7.7.4 Mitsubishi Electric (Japan) SCADA Revenue, Gross Margin and Market Share (2021-2026)
  7.7.5 Mitsubishi Electric (Japan) Recent Developments/Updates
  7.7.6 Mitsubishi Electric (Japan) Competitive Strengths & Weaknesses
7.8 Omron Corporation (Japan)
  7.8.1 Omron Corporation (Japan) Details
  7.8.2 Omron Corporation (Japan) Major Business
  7.8.3 Omron Corporation (Japan) SCADA Product and Services
  7.8.4 Omron Corporation (Japan) SCADA Revenue, Gross Margin and Market Share (2021-2026)
  7.8.5 Omron Corporation (Japan) Recent Developments/Updates
  7.8.6 Omron Corporation (Japan) Competitive Strengths & Weaknesses
7.9 General Electric Co. (US)
  7.9.1 General Electric Co. (US) Details
  7.9.2 General Electric Co. (US) Major Business
  7.9.3 General Electric Co. (US) SCADA Product and Services
  7.9.4 General Electric Co. (US) SCADA Revenue, Gross Margin and Market Share (2021-2026)
  7.9.5 General Electric Co. (US) Recent Developments/Updates
  7.9.6 General Electric Co. (US) Competitive Strengths & Weaknesses
7.10 Yokogawa Electric Corporation (Japan)
  7.10.1 Yokogawa Electric Corporation (Japan) Details
  7.10.2 Yokogawa Electric Corporation (Japan) Major Business
  7.10.3 Yokogawa Electric Corporation (Japan) SCADA Product and Services
  7.10.4 Yokogawa Electric Corporation (Japan) SCADA Revenue, Gross Margin and Market Share (2021-2026)
  7.10.5 Yokogawa Electric Corporation (Japan) Recent Developments/Updates
  7.10.6 Yokogawa Electric Corporation (Japan) Competitive Strengths & Weaknesses
7.11 Larsen & Toubro (India)
  7.11.1 Larsen & Toubro (India) Details
  7.11.2 Larsen & Toubro (India) Major Business
  7.11.3 Larsen & Toubro (India) SCADA Product and Services
  7.11.4 Larsen & Toubro (India) SCADA Revenue, Gross Margin and Market Share (2021-2026)
  7.11.5 Larsen & Toubro (India) Recent Developments/Updates
  7.11.6 Larsen & Toubro (India) Competitive Strengths & Weaknesses
7.12 M.B. Control & Systems Pvt. Ltd (India)
  7.12.1 M.B. Control & Systems Pvt. Ltd (India) Details
  7.12.2 M.B. Control & Systems Pvt. Ltd (India) Major Business
  7.12.3 M.B. Control & Systems Pvt. Ltd (India) SCADA Product and Services
  7.12.4 M.B. Control & Systems Pvt. Ltd (India) SCADA Revenue, Gross Margin and Market Share (2021-2026)
  7.12.5 M.B. Control & Systems Pvt. Ltd (India) Recent Developments/Updates
  7.12.6 M.B. Control & Systems Pvt. Ltd (India) Competitive Strengths & Weaknesses

8 INDUSTRY CHAIN ANALYSIS

8.1 SCADA Industry Chain
8.2 SCADA Upstream Analysis
8.3 SCADA Midstream Analysis
8.4 SCADA Downstream Analysis

9 RESEARCH FINDINGS AND CONCLUSION

10 APPENDIX

10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES

Table 1. World Transdermal Patch Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World Transdermal Patch Production Value by Region (2021-2026) & (USD Million)
Table 3. World Transdermal Patch Production Value by Region (2027-2032) & (USD Million)
Table 4. World Transdermal Patch Production Value Market Share by Region (2021-2026)
Table 5. World Transdermal Patch Production Value Market Share by Region (2027-2032)
Table 6. World Transdermal Patch Production by Region (2021-2026) & (M Pcs)
Table 7. World Transdermal Patch Production by Region (2027-2032) & (M Pcs)
Table 8. World Transdermal Patch Production Market Share by Region (2021-2026)
Table 9. World Transdermal Patch Production Market Share by Region (2027-2032)
Table 10. World Transdermal Patch Average Price by Region (2021-2026) & (USD/Pc)
Table 11. World Transdermal Patch Average Price by Region (2027-2032) & (USD/Pc)
Table 12. Transdermal Patch Major Market Trends
Table 13. World Transdermal Patch Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (M Pcs)
Table 14. World Transdermal Patch Consumption by Region (2021-2026) & (M Pcs)
Table 15. World Transdermal Patch Consumption Forecast by Region (2027-2032) & (M Pcs)
Table 16. World Transdermal Patch Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key Transdermal Patch Producers in 2025
Table 18. World Transdermal Patch Production by Manufacturer (2021-2026) & (M Pcs)
Table 19. Production Market Share of Key Transdermal Patch Producers in 2025
Table 20. World Transdermal Patch Average Price by Manufacturer (2021-2026) & (USD/Pc)
Table 21. Global Transdermal Patch Company Evaluation Quadrant
Table 22. World Transdermal Patch Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and Transdermal Patch Production Site of Key Manufacturer
Table 24. Transdermal Patch Market: Company Product Type Footprint
Table 25. Transdermal Patch Market: Company Product Application Footprint
Table 26. Transdermal Patch Competitive Factors
Table 27. Transdermal Patch New Entrant and Capacity Expansion Plans
Table 28. Transdermal Patch Mergers & Acquisitions Activity
Table 29. United States VS China Transdermal Patch Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China Transdermal Patch Production Comparison, (2021 & 2025 & 2032) & (M Pcs)
Table 31. United States VS China Transdermal Patch Consumption Comparison, (2021 & 2025 & 2032) & (M Pcs)
Table 32. United States Based Transdermal Patch Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Transdermal Patch Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers Transdermal Patch Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers Transdermal Patch Production (2021-2026) & (M Pcs)
Table 36. United States Based Manufacturers Transdermal Patch Production Market Share (2021-2026)
Table 37. China Based Transdermal Patch Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Transdermal Patch Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers Transdermal Patch Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers Transdermal Patch Production, (2021-2026) & (M Pcs)
Table 41. China Based Manufacturers Transdermal Patch Production Market Share (2021-2026)
Table 42. Rest of World Based Transdermal Patch Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers Transdermal Patch Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers Transdermal Patch Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers Transdermal Patch Production, (2021-2026) & (M Pcs)
Table 46. Rest of World Based Manufacturers Transdermal Patch Production Market Share (2021-2026)
Table 47. World Transdermal Patch Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World Transdermal Patch Production by Type (2021-2026) & (M Pcs)
Table 49. World Transdermal Patch Production by Type (2027-2032) & (M Pcs)
Table 50. World Transdermal Patch Production Value by Type (2021-2026) & (USD Million)
Table 51. World Transdermal Patch Production Value by Type (2027-2032) & (USD Million)
Table 52. World Transdermal Patch Average Price by Type (2021-2026) & (USD/Pc)
Table 53. World Transdermal Patch Average Price by Type (2027-2032) & (USD/Pc)
Table 54. World Transdermal Patch Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 55. World Transdermal Patch Production by Application (2021-2026) & (M Pcs)
Table 56. World Transdermal Patch Production by Application (2027-2032) & (M Pcs)
Table 57. World Transdermal Patch Production Value by Application (2021-2026) & (USD Million)
Table 58. World Transdermal Patch Production Value by Application (2027-2032) & (USD Million)
Table 59. World Transdermal Patch Average Price by Application (2021-2026) & (USD/Pc)
Table 60. World Transdermal Patch Average Price by Application (2027-2032) & (USD/Pc)
Table 61. Hisamitsu Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 62. Hisamitsu Pharmaceutical Major Business
Table 63. Hisamitsu Pharmaceutical Transdermal Patch Product and Services
Table 64. Hisamitsu Pharmaceutical Transdermal Patch Production (M Pcs), Price (USD/Pc), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 65. Hisamitsu Pharmaceutical Recent Developments/Updates
Table 66. Hisamitsu Pharmaceutical Competitive Strengths & Weaknesses
Table 67. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 68. Johnson & Johnson Major Business
Table 69. Johnson & Johnson Transdermal Patch Product and Services
Table 70. Johnson & Johnson Transdermal Patch Production (M Pcs), Price (USD/Pc), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 71. Johnson & Johnson Recent Developments/Updates
Table 72. Johnson & Johnson Competitive Strengths & Weaknesses
Table 73. Novartis Basic Information, Manufacturing Base and Competitors
Table 74. Novartis Major Business
Table 75. Novartis Transdermal Patch Product and Services
Table 76. Novartis Transdermal Patch Production (M Pcs), Price (USD/Pc), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 77. Novartis Recent Developments/Updates
Table 78. Novartis Competitive Strengths & Weaknesses
Table 79. UCB Pharma Basic Information, Manufacturing Base and Competitors
Table 80. UCB Pharma Major Business
Table 81. UCB Pharma Transdermal Patch Product and Services
Table 82. UCB Pharma Transdermal Patch Production (M Pcs), Price (USD/Pc), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 83. UCB Pharma Recent Developments/Updates
Table 84. UCB Pharma Competitive Strengths & Weaknesses
Table 85. Mylan Basic Information, Manufacturing Base and Competitors
Table 86. Mylan Major Business
Table 87. Mylan Transdermal Patch Product and Services
Table 88. Mylan Transdermal Patch Production (M Pcs), Price (USD/Pc), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 89. Mylan Recent Developments/Updates
Table 90. Mylan Competitive Strengths & Weaknesses
Table 91. Teva Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 92. Teva Pharmaceutical Major Business
Table 93. Teva Pharmaceutical Transdermal Patch Product and Services
Table 94. Teva Pharmaceutical Transdermal Patch Production (M Pcs), Price (USD/Pc), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 95. Teva Pharmaceutical Recent Developments/Updates
Table 96. Teva Pharmaceutical Competitive Strengths & Weaknesses
Table 97. Nitto Denko Basic Information, Manufacturing Base and Competitors
Table 98. Nitto Denko Major Business
Table 99. Nitto Denko Transdermal Patch Product and Services
Table 100. Nitto Denko Transdermal Patch Production (M Pcs), Price (USD/Pc), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 101. Nitto Denko Recent Developments/Updates
Table 102. Nitto Denko Competitive Strengths & Weaknesses
Table 103. Gr?nenthal Basic Information, Manufacturing Base and Competitors
Table 104. Gr?nenthal Major Business
Table 105. Gr?nenthal Transdermal Patch Product and Services
Table 106. Gr?nenthal Transdermal Patch Production (M Pcs), Price (USD/Pc), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 107. Gr?nenthal Recent Developments/Updates
Table 108. Gr?nenthal Competitive Strengths & Weaknesses
Table 109. IBSA Group Basic Information, Manufacturing Base and Competitors
Table 110. IBSA Group Major Business
Table 111. IBSA Group Transdermal Patch Product and Services
Table 112. IBSA Group Transdermal Patch Production (M Pcs), Price (USD/Pc), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 113. IBSA Group Recent Developments/Updates
Table 114. IBSA Group Competitive Strengths & Weaknesses
Table 115. GSK Basic Information, Manufacturing Base and Competitors
Table 116. GSK Major Business
Table 117. GSK Transdermal Patch Product and Services
Table 118. GSK Transdermal Patch Production (M Pcs), Price (USD/Pc), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 119. GSK Recent Developments/Updates
Table 120. GSK Competitive Strengths & Weaknesses
Table 121. Luye Pharma Group Basic Information, Manufacturing Base and Competitors
Table 122. Luye Pharma Group Major Business
Table 123. Luye Pharma Group Transdermal Patch Product and Services
Table 124. Luye Pharma Group Transdermal Patch Production (M Pcs), Price (USD/Pc), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 125. Luye Pharma Group Recent Developments/Updates
Table 126. Luye Pharma Group Competitive Strengths & Weaknesses
Table 127. Pfizer Basic Information, Manufacturing Base and Competitors
Table 128. Pfizer Major Business
Table 129. Pfizer Transdermal Patch Product and Services
Table 130. Pfizer Transdermal Patch Production (M Pcs), Price (USD/Pc), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 131. Pfizer Recent Developments/Updates
Table 132. Pfizer Competitive Strengths & Weaknesses
Table 133. Chattem Basic Information, Manufacturing Base and Competitors
Table 134. Chattem Major Business
Table 135. Chattem Transdermal Patch Product and Services
Table 136. Chattem Transdermal Patch Production (M Pcs), Price (USD/Pc), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 137. Chattem Recent Developments/Updates
Table 138. Chattem Competitive Strengths & Weaknesses
Table 139. Dr Reddy’s Laboratories Basic Information, Manufacturing Base and Competitors
Table 140. Dr Reddy’s Laboratories Major Business
Table 141. Dr Reddy’s Laboratories Transdermal Patch Product and Services
Table 142. Dr Reddy’s Laboratories Transdermal Patch Production (M Pcs), Price (USD/Pc), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 143. Dr Reddy’s Laboratories Recent Developments/Updates
Table 144. Dr Reddy’s Laboratories Competitive Strengths & Weaknesses
Table 145. Bayer Basic Information, Manufacturing Base and Competitors
Table 146. Bayer Major Business
Table 147. Bayer Transdermal Patch Product and Services
Table 148. Bayer Transdermal Patch Production (M Pcs), Price (USD/Pc), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 149. Bayer Recent Developments/Updates
Table 150. Bayer Competitive Strengths & Weaknesses
Table 151. Mundipharma Basic Information, Manufacturing Base and Competitors
Table 152. Mundipharma Major Business
Table 153. Mundipharma Transdermal Patch Product and Services
Table 154. Mundipharma Transdermal Patch Production (M Pcs), Price (USD/Pc), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 155. Mundipharma Recent Developments/Updates
Table 156. Mundipharma Competitive Strengths & Weaknesses
Table 157. Endo International Basic Information, Manufacturing Base and Competitors
Table 158. Endo International Major Business
Table 159. Endo International Transdermal Patch Product and Services
Table 160. Endo International Transdermal Patch Production (M Pcs), Price (USD/Pc), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 161. Endo International Recent Developments/Updates
Table 162. Endo International Competitive Strengths & Weaknesses
Table 163. Beijing Tide Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 164. Beijing Tide Pharmaceutical Major Business
Table 165. Beijing Tide Pharmaceutical Transdermal Patch Product and Services
Table 166. Beijing Tide Pharmaceutical Transdermal Patch Production (M Pcs), Price (USD/Pc), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 167. Beijing Tide Pharmaceutical Recent Developments/Updates
Table 168. Beijing Tide Pharmaceutical Competitive Strengths & Weaknesses
Table 169. Global Key Players of Transdermal Patch Upstream (Raw Materials)
Table 170. Global Transdermal Patch Typical Customers
Table 171. Transdermal Patch Typical Distributors

LIST OF FIGURES

Figure 1. Transdermal Patch Picture
Figure 2. World Transdermal Patch Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Transdermal Patch Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World Transdermal Patch Production (2021-2032) & (M Pcs)
Figure 5. World Transdermal Patch Average Price (2021-2032) & (USD/Pc)
Figure 6. World Transdermal Patch Production Value Market Share by Region (2021-2032)
Figure 7. World Transdermal Patch Production Market Share by Region (2021-2032)
Figure 8. North America Transdermal Patch Production (2021-2032) & (M Pcs)
Figure 9. Europe Transdermal Patch Production (2021-2032) & (M Pcs)
Figure 10. China Transdermal Patch Production (2021-2032) & (M Pcs)
Figure 11. Japan Transdermal Patch Production (2021-2032) & (M Pcs)
Figure 12. India Transdermal Patch Production (2021-2032) & (M Pcs)
Figure 13. Israel Transdermal Patch Production (2021-2032) & (M Pcs)
Figure 14. Transdermal Patch Market Drivers
Figure 15. Factors Affecting Demand
Figure 16. World Transdermal Patch Consumption (2021-2032) & (M Pcs)
Figure 17. World Transdermal Patch Consumption Market Share by Region (2021-2032)
Figure 18. United States Transdermal Patch Consumption (2021-2032) & (M Pcs)
Figure 19. China Transdermal Patch Consumption (2021-2032) & (M Pcs)
Figure 20. Europe Transdermal Patch Consumption (2021-2032) & (M Pcs)
Figure 21. Japan Transdermal Patch Consumption (2021-2032) & (M Pcs)
Figure 22. South Korea Transdermal Patch Consumption (2021-2032) & (M Pcs)
Figure 23. ASEAN Transdermal Patch Consumption (2021-2032) & (M Pcs)
Figure 24. India Transdermal Patch Consumption (2021-2032) & (M Pcs)
Figure 25. Producer Shipments of Transdermal Patch by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 26. Global Four-firm Concentration Ratios (CR4) for Transdermal Patch Markets in 2025
Figure 27. Global Four-firm Concentration Ratios (CR8) for Transdermal Patch Markets in 2025
Figure 28. United States VS China: Transdermal Patch Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. United States VS China: Transdermal Patch Production Market Share Comparison (2021 & 2025 & 2032)
Figure 30. United States VS China: Transdermal Patch Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 31. United States Based Manufacturers Transdermal Patch Production Market Share 2025
Figure 32. China Based Manufacturers Transdermal Patch Production Market Share 2025
Figure 33. Rest of World Based Manufacturers Transdermal Patch Production Market Share 2025
Figure 34. World Transdermal Patch Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 35. World Transdermal Patch Production Value Market Share by Type in 2025
Figure 36. Methyl Salicylate-based Patch
Figure 37. Rivastigmine Transdermal Patch
Figure 38. Fentanyl Transdermal Patch
Figure 39. Lidocaine Patch
Figure 40. Diclofenac Patch
Figure 41. Nicotine Transdermal Patch
Figure 42. Others
Figure 43. Others
Figure 44. World Transdermal Patch Production Market Share by Type (2021-2032)
Figure 45. World Transdermal Patch Production Value Market Share by Type (2021-2032)
Figure 46. World Transdermal Patch Average Price by Type (2021-2032) & (USD/Pc)
Figure 47. World Transdermal Patch Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 48. World Transdermal Patch Production Value Market Share by Application in 2025
Figure 49. Rx Channel
Figure 50. OTC Channel
Figure 51. World Transdermal Patch Production Market Share by Application (2021-2032)
Figure 52. World Transdermal Patch Production Value Market Share by Application (2021-2032)
Figure 53. World Transdermal Patch Average Price by Application (2021-2032) & (USD/Pc)
Figure 54. Transdermal Patch Industry Chain
Figure 55. Transdermal Patch Procurement Model
Figure 56. Transdermal Patch Sales Model
Figure 57. Transdermal Patch Sales Channels, Direct Sales, and Distribution
Figure 58. Methodology
Figure 59. Research Process and Data Source


More Publications